@article{ART002702676,
author={Terry Cheuk-Fung Yip and Grace Lai-Hung Wong and Vincent Wai-Sun Wong},
title={Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact},
journal={Clinical and Molecular Hepatology},
issn={2287-2728},
year={2021},
volume={27},
number={2},
pages={273-277},
doi={10.3350/cmh.2021.0019}
}

TY - JOUR
AU - Terry Cheuk-Fung Yip
AU - Grace Lai-Hung Wong
AU - Vincent Wai-Sun Wong
TI - Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
T2 - Clinical and Molecular Hepatology
JO - Clinical and Molecular Hepatology
PY - 2021
VL - 27
IS - 2
PB - 대한간학회
SP - 273
EP - 277
SN - 2287-2728
AB -
KW - Hepatitis B, Immune tolerance, Fibrosis-4 index, Liver fibrosis
DO - 10.3350/cmh.2021.0019
ER -

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong and Vincent Wai-Sun Wong. 2021, "Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact", Clinical and Molecular Hepatology, vol.27, no.2 pp.273-277. Available from: doi:10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong "Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact" Clinical and Molecular Hepatology 27.2 pp.273-277 (2021) : 273.

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact. 2021; 27(2), 273-277. Available from: doi:10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong and Vincent Wai-Sun Wong. "Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact" Clinical and Molecular Hepatology 27, no.2 (2021) : 273-277.doi: 10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip; Grace Lai-Hung Wong; Vincent Wai-Sun Wong. Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact. Clinical and Molecular Hepatology, 27(2), 273-277. doi: 10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip; Grace Lai-Hung Wong; Vincent Wai-Sun Wong. Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact. Clinical and Molecular Hepatology. 2021; 27(2) 273-277. doi: 10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact. 2021; 27(2), 273-277. Available from: doi:10.3350/cmh.2021.0019

Terry Cheuk-Fung Yip, Grace Lai-Hung Wong and Vincent Wai-Sun Wong. "Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact" Clinical and Molecular Hepatology 27, no.2 (2021) : 273-277.doi: 10.3350/cmh.2021.0019